why choose us

First received: August 15, 2023

Clinical Trial: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Study Status: Completed

Recruit Status: RECRUITING

Condition: Carcinoma, Squamous Cell of Head and Neck

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2

Brief Summary: This clinical trial is studying advanced or metastatic solid tumors.Once a solid tumor has grown very large in one spot or has spread to other places in the body, it is called advanced or metastatic cancer.Participants in this study must have head and neck squamous cell cancer, non-small cell lung cancer, endometrial cancer, or ovarian cancer.Participants must have tumors that have a marker called HER2.This clinical trial uses an experimental drug called disitamab vedotin (DV).DV is a type of antibody-drug…

Read more